Nouveau Life Pharmaceuticals (Nouveau Life Pharmaceuticals) Enterprise Value : $1.33 Mil (As of May. 15, 2024)

Nouveau Life Pharmaceuticals Enterprise Value Chart

Nouveau Life Pharmaceuticals Quarterly Data
	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08
Enterprise Value	Get a 7-Day Free Trial															12.67	9.38	7.59	7.01	5.18

Competitive Comparison of Nouveau Life Pharmaceuticals's Enterprise Value

For the Health Information Services subindustry, Nouveau Life Pharmaceuticals's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nouveau Life Pharmaceuticals's Enterprise Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nouveau Life Pharmaceuticals's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Nouveau Life Pharmaceuticals's Enterprise Value falls into.

Nouveau Life Pharmaceuticals Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Nouveau Life Pharmaceuticals's Enterprise Value for the fiscal year that ended in Jun. 2006 is calculated as

Nouveau Life Pharmaceuticals's Enterprise Value for the quarter that ended in Mar. 2008 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nouveau Life Pharmaceuticals  (OTCPK:NOUV) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Nouveau Life Pharmaceuticals's EV-to-EBIT for today is

Nouveau Life Pharmaceuticals's current Enterprise Value is $1.33 Mil.
Nouveau Life Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Mar. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.50 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Nouveau Life Pharmaceuticals's EV-to-EBITDA for today is:

Nouveau Life Pharmaceuticals's current Enterprise Value is $1.33 Mil.
Nouveau Life Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Mar. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.24 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Nouveau Life Pharmaceuticals's EV-to-Revenue for today is:

Nouveau Life Pharmaceuticals's current Enterprise Value is $1.33 Mil.
Nouveau Life Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Mar. 2008 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nouveau Life Pharmaceuticals Enterprise Value Related Terms

Thank you for viewing the detailed overview of Nouveau Life Pharmaceuticals's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Nouveau Life Pharmaceuticals (Nouveau Life Pharmaceuticals) Business Description